Notably in this respect, the conserved upregulation or de novo synthesis of IGF2BP1 in cancer is primarily observed in progressed, de-differentiated malignancies, as demonstrated for instance in anaplastic thyroid carcinoma (48). The gene discussed is IGF2BP1; the disease is cancer.